Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
Auto-immune diseases
Chronic kidney disease
High-density lipoproteins
Infectious diseases
Inflammation
Metabolic diseases
Neurological diseases
Journal
Advanced drug delivery reviews
ISSN: 1872-8294
Titre abrégé: Adv Drug Deliv Rev
Pays: Netherlands
ID NLM: 8710523
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
01
2020
revised:
20
09
2020
accepted:
13
10
2020
pubmed:
21
10
2020
medline:
28
8
2021
entrez:
20
10
2020
Statut:
ppublish
Résumé
High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially contributes to the reverse cholesterol transport pathway. Over recent years it has become clear that the effect of HDL on immune-modulation is not only dependent on HDL concentration but also and perhaps even more so on HDL function. This review will provide a concise general introduction to HDL followed by an overview of post-translational modifications of HDL and a detailed overview of the role of HDL in inflammatory diseases. The clinical potential of HDL and its main apolipoprotein constituent, apoA-I, is also addressed in this context. Finally, some conclusions and remarks that are important for future HDL-based research and further development of HDL-focused therapies are discussed.
Identifiants
pubmed: 33080259
pii: S0169-409X(20)30143-5
doi: 10.1016/j.addr.2020.10.006
pii:
doi:
Substances chimiques
APOA1 protein, human
0
Apolipoprotein A-I
0
Lipoproteins, HDL
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
94-119Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.